Suspicious cells build up in mice that haven’t given birth, a new study finds. They could help explain a longstanding mystery ...

As a world leader in the immuno-oncology field, Dr. Zihai Li has long been at the forefront of cancer immunotherapy.

A cancer drug class best known for attacking tumors may also help your immune system remember them better. Researchers at ...

Scientists have uncovered new genetic rules that determine whether the immune system’s “killer” T cells remain powerful long-term defenders or become worn out and ineffective. By building a detailed ...

Obesity is now linked to at least 13 types of cancer, making it one of the most preventable cancer risk factors in the United ...

Major WHO study analyzing 30 years of research finally settles whether cell phones cause cancer - the results may surprise you.

After nearly a decade of treatment, a Texas woman reached remission through an FDA-approved cellular therapy for chronic lymphocytic leukemia.

Fred Hutch Cancer Center scientists have developed an experimental strategy to give genetically engineered CAR T cells help they'd normally find within lymph nodes — but on the go, within the tumor.

A modified herpes virus boosted immune T cell infiltration in glioblastoma tumors and was associated with improved survival.

UCLA scientists have developed a next-generation CAR-T cell therapy that can overcome the immunosuppressive tumor microenvironment, a protective shield that tumors use to weaken immune cells, block ...

A group of natural compounds attracting attention for their anti-aging potential has a dark side. New research shows how a ...

UCLA scientists have developed a next-generation CAR-T cell therapy that can overcome the immunosuppressive tumor microenvironment, a protective shield that tumors use to weaken immune cells, block ...